Persistence Market Research
Antiplatelet drugs are wrongly referred to as the blood thinning drugs. They don’t thin the blood but instead interfere with the important process by which blood clots. Antiplatelet agent normally decrease the clumping of blood cells thereby decreasing the potentially harmful blood clots. People who are at high risk of heart disease when given antiplatelet agents, their risks of strokes and heart attacks can be avoided.
Antiplatelet agents are widely used in patients having heart attacks as most of the heart attacks are caused by clots in the arteries that feed the heart muscle. Moreover, these are also used in patients who undergo surgical procedure such as angioplasty, which is used to unblock an artery through the insertion of a tube called stent.
Antiplatelet Drugs Market: Drivers and Restraints
The antiplatelet drug market is expected to propel during the forecast period owing to the increasing organic and inorganic growth taking place within the industry. Moreover, the market for generic is also at a rise thereby giving a boost to the generic antiplatelet drug manufacturers. The amount of money which the companies are spending towards research and development is also expected to contribute towards the revenue of the antiplatelet drugs market in the future. For instance in February 2017, PLx Pharma announced positive antiplatelet data for its Aspertec drug which was published in the Journal of the American College of Cardiology (JACC). Now researchers are concentrating on analyzing the pharmacodynamics and meta-analyses to determine whether one drug has an edge over other.
Antiplatelet Drugs Market: Segmentation
On the basis of drug type, the antiplatelet drugs market can be segmented as:
On the basis of application, the antiplatelet drugs market can be segmented as:
On the basis of end user the antiplatelet drugs market can be segment as
Antiplatelet Drugs Market: Overview
Aspirin is a very well-known antiplatelet drug which has been used since a very long time. Along with Aspirin, there are other three drugs which were approved by FDA in the 1990s. Plavix in 1997, Ticlid in 1991 and Aggrenox in 1999. After these set of drugs Effient was approved by the FDA in 2009. Antiplatelet drugs are just one type of medicine used to treat people with stroke and heart attack. The antiplatelet drugs are usually given along with other medication, lifestyle changes and nondrug treatment to keep the heart healthy.
Antiplatelet Drugs Market: Region-wise Outlook
In terms of geography, Antiplatelet Drugs market has been divided into five regions including North- America, Asia- Pacific, Middle-East & Africa, Latin America and Europe. North America is the dominating region with the number of players initiating clinical trials for the antiplatelet drugs. Moreover, there are many academic universities receiving research grants to develop new product alternatives. For instance, Kengreal, an intravenous antiplatelet drug developed by The Medicines Company received FDA approval. As Asia Pacific is an economically developing country it is expected to spearhead during the forecast period.
Antiplatelet Drugs Market: Key Market Participants
Some of the Antiplatelet Drugs market participants are The Medicines Company, AstraZeneca, The Medicines Company, Portola Pharmaceuticals, Inc., Bayer Pharmaceuticals , Bristol-Myers Squibb Company, Boehringer Ingelheim Pharmaceuticals, Inc. , Altimed Pharma Inc., Dominion Pharmacal, Alta Laboratories Ltd, Novacap, Shandong Xinhua Pharmaceutical, Nanjing Pharmaceutical Factory, Sanis Health Inc, Syntex Inc., Hoffmann La Roche, Teva, Sandoz Canada Incorporated, Pharmascience Inc, Nu Pharm Inc and Mylan Pharmaceuticals
MRR.BIZ has been compiled in-depth market research data in the report after exhaustive primary and secondary research. Our team of able, experienced in-house analysts has collated the information through personal interviews and study of industry databases, journals, and reputable paid sources.
The report provides the following information:
The main aim of the report is to:
MRR.BIZ is a leading provider of strategic market research. Our vast repository consists research reports, data books, company profiles, and regional market data sheets. We regularly update the data and analysis of a wide-ranging products and services around the world. As readers, you will have access to the latest information on almost 300 industries and their sub-segments. Both large Fortune 500 companies and SMEs have found those useful. This is because we customize our offerings keeping in mind the specific requirements of our clients.